Skip to main content
Clinical Trials/CTRI/2022/07/044468
CTRI/2022/07/044468
Completed
Phase 3

Evaluation of Efficacy and Safety of Namskar Ayurved’s Repair and Restore Moisturizing Body Oil in Healthy participants - An open label, non-comparative, interventional, prospective, clinical study - NI

amaskar Ayurved Private Limited0 sites33 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
amaskar Ayurved Private Limited
Enrollment
33
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
December 7, 2022
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
amaskar Ayurved Private Limited

Eligibility Criteria

Inclusion Criteria

  • 1\.Clinically diagnosed mild to moderate skin dryness assessed using clinical grading score
  • 2\.Willing to comply with all requirements of the study.

Exclusion Criteria

  • 1\.Subjects with a known current history of chronic skin diseases or autoimmune diseases, such as atopic dermatitis, psoriasis, chronic urticaria, vitiligo and rosacea
  • 2\.Subjects with a tattoo, a scar, moles, too many hairs or anything on the Right leg which might interfere with the evaluation.
  • 3\.Subjects with intensive exposure to sunlight or UV\-rays within the previous month and foreseen during the study.
  • 4\.Subjects who have used facial blemish\-lightening products (such as products claiming to have whitening or blemish\-lightening effects), topical or oral whitening drugs. Moisturizing cream, lotion or oil within 21 days before entering the trial
  • 5\.Subjects on any other investigational products within 1 month prior to randomization
  • 6\.Subjects with known current tuberculosis, HIV, ischemic heart disease, cancer, kidney failure, liver failure
  • 7\.Pregnant and lactating women
  • 8\.Known hypersensitivity to any of the ingredients of Namskar Ayurved’s Repair and Restore Moisturizing Body Oil
  • 9\.Other conditions, which in the opinion of the investigators, make patient unsuitable for enrolment or could interfere with his/her participation in, and completion of the study

Outcomes

Primary Outcomes

Not specified

Similar Trials